查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837401

植入市场按产品类型、材料、最终用户和分销管道划分－2025-2032年全球预测

Bio-implant Market by Product Type, Material, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，植入市场规模将达到 1,110.6 亿美元，复合年增长率为 4.91%。

主要市场统计数据
基准年 2024 756.5亿美元
预计年份：2025年 794.5亿美元
预测年份：2032年 1110.6亿美元
复合年增长率 (%) 4.91%

这是一份策略性介绍，旨在阐明植入创新、监管演变、临床需求和商业化重点在当今医疗保健生态系统中的地位。

本执行摘要概述了生物植入物领域复杂的环境，其中技术创新、监管演变和不断变化的医疗模式相互交织，为植入相关人员创造了新的机会和营运挑战。新型生物植入物植入和材料科学的进步正在重新定义植入的性能和耐久性，而对价值导向医疗的日益重视也推动了对临床结果评估和成本透明度的新需求。同时，临床医生、工程师和支付方之间的跨领域合作正在加速将有前景的概念从实验室转化为临床应用。

在此背景下，企业主管必须协调策略要务（例如加速创新週期、加强供应链和提升支付方参与度）与战术性重点（例如植入选择、外科医生培训和上市后监测）。因此，有效的策略需要在差异化技术投资与务实方法（例如监管合规、临床医生采纳和分销灵活性）之间取得平衡。透过这种方式，企业可以巩固其在医疗保健生态系统中的地位，并在管控临床、财务和营运风险的同时，为患者带来可衡量的益处。

本文概述了技术、监管和护理模式的关键转变，这些转变正在重新定义植入开发商向患者和医疗保健提供者提供治疗方法的方式。

由于技术、政策和临床领域各方力量的汇聚，植入领域正经历显着的变化。生物材料的进步和设备小型化使得微创手术成为可能，并延长了设备的使用寿命，从而改变了医保报销的模式和临床应用管道。同时，远端监测和追踪等数位医疗辅助技术的应用正在重塑术后护理，并为植入与患者数据生态系统的整合创造了机会。

法律规范也朝着更加重视真实世界证据和持续安全监测的方向发展，这提高了製造商证明其产品长期性能和以患者为中心的疗效的标准。供应链重组和对区域韧性的关注正促使企业实现采购和製造地的多元化。总而言之，这些转变要求企业采用敏捷的商业化模式，优先考虑临床检验、资料互通性和伙伴关係，以满足新的市场需求并维持长期成长。

分析2025年关税政策对植入产业供应链、采购决策和生产韧性的实际和策略影响

2025年关税政策对製造商、供应商和医疗保健机构产生了多方面的影响，远不止成本大幅调整那么简单。关税变化凸显了在地化生产策略和供应商多元化对于降低跨境贸易中断风险的重要性。对于依赖国际采购的企业而言，最直接的影响是加速推进近岸外包倡议，并评估替代材料供应商，以在确保产品品质的同时，尽可能减少利润损失。

此外，医院和门诊手术中心的采购团队已开始重新评估供应商合约和整体拥有成本 (TCO)，权衡不断上涨的房地产购置成本与临床绩效指标。为此，製造商正优先考虑透明的成本模型、模组化产品设计以实现零件互换性，以及策略性库存管理以维持供应的连续性。从长远来看，这些调整正在影响合约动态，塑造供应商选择标准，并促使企业重新专注于製造灵活性和监管协调，以维持全球市场进入。

将产品类型、材料选择、临床终端用户和分销管道与可操作的商业化和研发重点联繫起来的详细细分洞察

对市场区隔进行细緻入微的分析，可以揭示临床需求与材料科学和分销行为的交汇点，以及这些交会点应如何在产品组合策略中体现。依产品类型划分，我们提供心血管植入，包括人工心臟瓣膜、起搏器、支架和血管移植物；人工植牙，包括骨内、骨膜下和经骨膜系统；神经植入，包括深层脑部刺激器、神经假体和脊髓刺激设备；以及整形外科植入，包括髋关节、膝关节、肩关节和脊柱植入物，其中髋关节植入物这些产品差异反映了不同的临床工作流程、报销管道和外科医生培训要求，因此需要量身定制证据产生和市场推广策略。

从材料分类来看，主要类别包括陶瓷、复合材料、聚合物和钛，其中聚合物可细分为可生物降解聚合物和超高分子量聚乙烯。材料的选择必须与临床终点和生产能力相匹配，因为它直接影响器械的使用寿命、生物相容性、灭菌方案和监管文件。从终端使用者的角度来看，门诊手术中心、诊所、医院和研究机构的需求分布表明，它们的采购週期、竞标流程和临床实施时间表各不相同。

最后，通路动态取决于线上和线下分销模式的共存。虽然线下管道在临床试验和需要无菌物流的高度复杂器械领域仍然占据主导地位，但线上管道正在逐步扩展到辅助组件、耗材和资讯传播领域。因此，策略性細項分析必须整合产品复杂性、材料限制、终端用户购买行为和通路适用性等因素，以便确定投资和营运重点的优先顺序。

全球主要市场的关键区域动态和差异化策略，旨在协调监管环境、临床实践和采购行为。

区域动态透过不同的管理体制、支付方格局和临床基础设施塑造竞争优势，因此，基于地理因素的策略对于有效进入和拓展市场至关重要。在美洲，强大的公私支付方参与以及先进的外科手术网络正在推动高价值植入的快速普及，同时也要求提供严格的成本效益和长期疗效证据。同时，欧洲、中东和非洲是一个异质性环境，监管协调工作与各国报销政策的差异并存，因此需要灵活的市场进入计划和本地合作伙伴关係，以确保处方笺获得批准和临床医生的认可。

亚太地区拥有庞大的规模化发展机会，这得益于其庞大的手术量、不断增长的医疗保健投资以及良好的製造业生态系统。然而，成功与否取决于产品能否适应当地的临床实践和价格敏感度。由于各全部区域的临床训练标准、采购週期和医院基础设施存在差异，因此需要针对特定地区的临床证据包装、定价策略和供应链配置进行调整。区域优先排序和客製化的合作模式正在加速产品应用，同时降低执行风险。

竞争行为分析表明，产品平台思维、临床伙伴关係和供应链韧性如何创造可衡量的差异化和商业性优势。

植入领域的主要企业正利用技术差异化、临床伙伴关係和营运规范结合的方式，确立自身的竞争优势。成功的企业正投资开发模组化平台，以加快不同型号产品的上市速度，并利用与领先临床中心的伙伴关係，以取得可靠的真实世界证据。这些企业也优先发展材料科学创新，将先进聚合物、陶瓷和钛合金与表面处理技术结合，以提高生物相容性、降低重新置换率，并增强临床和医疗保险方面的说服力。

从营运角度来看，一流企业正透过多通路采购、区域製造地和数位化追溯解决方案建构具有韧性的供应链，以满足监管要求并控制关税风险。此外，将数位健康功能（例如远端监测和数据分析）整合到植入式医疗设备中的企业，能够提供差异化的提案，从而支援更完善的疗效评估和上市后监测。因此，兼具临床可靠性、材料和设计创新以及灵活商业模式的企业，其竞争优势日益凸显。

为领导阶层提供切实可行的建议，这些建议结合了产品平台策略、证据产生、供应链韧性以及能够带来可衡量影响的有针对性的市场推广策略。

领导者应采取平衡的策略，透过有针对性的投资和切实可行的营运变革，在加速创新的同时降低商业化风险。首先，应优先发展模组化产品平台和可製造性设计，以实现零件替换和加快监管审批流程。同时，应投资于严谨的真实世界证据项目和结构化的上市后测试，以验证长期疗效并支持与支付方的谈判。此类数据倡议应与临床合作伙伴协调，以确保其有效性和应用价值。

第二，透过供应商多元化、评估近岸外包机会以及实施数位化追溯系统来增强供应链韧性，从而提高库存可见度和合规性。第三，根据区域和终端使用者的实际情况，调整定价、临床证据和培训计划，以满足医院、门诊手术中心、诊所和研究机构的特定需求，从而製定符合当地实际情况的打入市场策略进入策略。最后，采用远端监测和患者互动工具等数位化工具，以增强植入价值提案并促进以结果主导的合约签订。这些措施有助于机构增强临床信心、降低营运风险并确保可持续的收入管道。

对严谨的多方法研究途径、主要相关人员访谈以及用于获取可靠且可操作见解的分析技术进行了清晰的阐述。

本报告采用多方法研究途径，结合一手质性访谈、二手文献回顾和比较个案分析，以确保分析的严谨性和实用性。一手研究包括对临床医生、采购负责人、相关人员和设备工程师进行结构化访谈，以了解不同相关人员对临床效用、推广障碍和采购标准的观点。这些见解与二手资讯（包括同行评审的临床研究、监管文件和公开的政策文件）进行三角验证，以检验趋势并支持技术论点。

分析方法包括情境对比分析，以检验不同监管和贸易条件下的策略应对措施；以及跨区域基准化分析，以识别市场进入和供应链设计的最佳实践。品管包括来源检验、专家同行评审和敏感性检查，以确保研究结果的可靠性和可操作性。整体而言，重点在于对产品开发、商业策略和营运执行的实际意义。

这份简明扼要的结论总结强化了将技术进步转化为临床应用和永续商业性成功的策略重点。

摘要：植入产业正处于技术快速发展和日益复杂的商业营运的交汇点，需要製定兼顾技术创新与务实开展业务的整合策略。将平台设计、材料专业知识和可靠的真实世界证据与稳健的供应链和区域性市场推广计划相结合的利益相关者，最能将科学进步转化为可持续的商业性成功。此外，不断变化的关税和法规环境凸显了灵活的生产和筹资策略的重要性，相关人员策略既要保护净利率，又要确保临床品质。

展望未来，积极投资临床医师伙伴关係、上市后数据系统和数位化支援工具的机构，不仅能改善病患疗效，还能加强与支付方的沟通，并为自身的长期发展奠定基础。要实现这一目标，需要有条不紊地进行优先排序、跨部门协调，并愿意根据新的证据和地缘政治现实调整经营模式。这样做将使企业能够在应对快速变化的全球医疗保健体系中固有风险的同时，抓住新的机会。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 生物可降解神经介面植入的进展将增强脑机通信
  • 将无线电力传输技术整合到长期心臟设备中
  • 人工智慧驱动的预测性维护系统的出现，旨在优化整形外科植入的性能
  • 开发嵌入生长因子的3D列印患者特异性支架以促进癒合
  • 植入式生物电子医疗设备安全测试全球监管标准的趋同

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型植入市场

  • 心血管植入
    • 人工心臟瓣膜
    • 起搏器
    • 支架
    • 血管移植
  • 人工植牙
    • 骨内植入
    • 骨膜下植入
    • 骨穿透性植入
  • 神经植入
    • 深层脑部刺激器
    • 神经假体
    • 脊髓刺激设备
  • 眼科植入
    • 角膜植入
    • 人工水晶体
    • 视网膜植入
  • 整形外科植入
    • 髋植入
      • 髋重组
      • 全髋置换术
    • 膝关节植入
      • 部分膝关节关节重建
      • 全膝关节关节重建
    • 肩关节关节移植
    • 脊椎移植

第九章植入市场（依材料划分）

  • 陶瓷製品
  • 复合材料
  • 聚合物
    • 可生物降解聚合物
    • UHMWPE
  • 钛

第十章 依最终用户分類的植入市场

  • 门诊手术中心
  • 诊所
  • 医院
  • 研究所

第十一章植入市场（依分销管道划分）

  • 离线
  • 在线的

第十二章植入市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章植入市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国植入市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • BioHorizons
    • Dentsply Sirona Inc
    • HIOSSEN
    • Institut Straumann AG
    • MEGA'GEN IMPLANT CO.,LTD.
    • Nobel Biocare Services AG
    • NuVasive, Inc.
    • OSSTEM IMPLANT CO., LTD.
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc
Product Code: MRR-0355054AC501

The Bio-implant Market is projected to grow by USD 111.06 billion at a CAGR of 4.91% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 75.65 billion
Estimated Year [2025] USD 79.45 billion
Forecast Year [2032] USD 111.06 billion
CAGR (%) 4.91%

A strategic introduction that positions bio-implant innovation, regulatory evolution, clinical demand, and commercialization priorities within today's healthcare ecosystem

This executive summary frames a complex environment where technological innovation, regulatory evolution, and shifting care models converge to create new opportunities and operational challenges for bio-implant stakeholders. Emerging device architectures and material science advances are redefining device performance and durability, while the growing emphasis on value-based care places new demands on clinical outcome measurement and cost transparency. Meanwhile, cross-discipline collaboration between clinicians, engineers, and payers is increasing the rate at which promising concepts move from bench to bedside.

Against this backdrop, executives must reconcile strategic imperatives-such as faster innovation cycles, supply chain resilience, and payer engagement-with tactical priorities like implant selection, surgical training, and post-market surveillance. Effective strategies will therefore balance investment in differentiated technologies with practical approaches to regulatory compliance, clinician adoption, and distribution agility. In doing so, organizations can strengthen their position within healthcare ecosystems and deliver measurable patient benefits while managing clinical, financial, and operational risk.

An overview of the major technological, regulatory, and care model shifts that are redefining how bio-implant developers bring therapies to patients and providers

The landscape for bio-implants is undergoing transformative shifts driven by converging forces across technology, policy, and clinical practice. Advances in biomaterials and device miniaturization are enabling less invasive procedures and extending device longevity, which in turn alters reimbursement conversations and clinical pathways. Concurrently, the adoption of digital health adjuncts such as remote monitoring and tele-follow up is reshaping post-operative care, creating opportunities for implants that integrate with patient data ecosystems.

Regulatory frameworks are also moving toward increased emphasis on real-world evidence and continuous safety monitoring, which raises the bar for manufacturers to demonstrate longitudinal performance and patient-centered outcomes. Supply chain reconfiguration and a focus on regional resilience are prompting firms to diversify sourcing and manufacturing footprints. Taken together, these shifts require companies to adopt nimble commercialization models that prioritize clinical validation, data interoperability, and collaborative partnerships to capture emerging demand and sustain long-term growth.

An analysis of the practical and strategic consequences of the 2025 tariff landscape on supply chains, procurement decisions, and manufacturing resilience across the bio-implant sector

The tariff actions introduced in 2025 have created a layered set of implications for manufacturers, suppliers, and healthcare providers that extend beyond headline cost adjustments. Tariff changes have increased the importance of localized production strategies and supplier diversification to mitigate exposure to cross-border trade disruptions. For organizations reliant on international sourcing, the immediate effect has been an acceleration of nearshoring initiatives and an evaluation of alternate material suppliers to preserve device quality while limiting margin erosion.

Furthermore, procurement teams within hospitals and ambulatory surgical centers have begun to re-assess vendor contracts and total cost of ownership, weighing increased landed costs against clinical performance metrics. In response, manufacturers have prioritized transparent cost models, modular product designs that allow component substitution, and strategic inventory management to maintain continuity of supply. Over time, these adaptations are influencing contractual dynamics, shaping supplier selection criteria, and prompting renewed emphasis on manufacturing flexibility and regulatory harmonization to sustain global market access.

In-depth segmentation insights that connect product categories, material choices, clinical end users, and distribution channels to practical commercialization and R&D priorities

A nuanced view of segmentation reveals where clinical demand intersects with material science and distribution behaviors, and how those intersections should inform portfolio strategy. Based on product type, the market spans cardiovascular implants including artificial heart valves, pacemakers, stents, and vascular grafts; dental implants such as endosseous, subperiosteal, and transosteal systems; neurological implants including deep brain stimulators, neuroprosthetics, and spinal cord stimulators; ophthalmic implants encompassing corneal substitutes, intraocular lenses, and retinal devices; and orthopedic implants with hip, knee, shoulder, and spinal options, where hip devices further differentiate into hip resurfacing and total hip replacement and knee solutions distinguish partial knee replacement from total knee replacement. These product distinctions reflect divergent clinical workflows, reimbursement pathways, and surgeon training requirements, and they necessitate tailored evidence generation and go-to-market approaches.

Turning to material segmentation, key categories include ceramic, composite, polymer, and titanium, with polymers subdivided into biodegradable polymers and ultra-high molecular weight polyethylene variants. Material choice has direct implications for device longevity, biocompatibility, sterilization protocols, and regulatory dossiers, and therefore must align with clinical endpoints and manufacturing capabilities. From an end-user perspective, the distribution of demand across ambulatory surgical centers, clinics, hospitals, and research institutes indicates differing purchasing cycles, tender processes, and clinical adoption timelines; each end-user type presents unique requirements for packaging, training, and post-sales support.

Finally, channel dynamics hinge on the coexistence of offline and online distribution models. Offline channels remain dominant for high-complexity devices requiring clinical demonstrations and sterile logistics, while online channels are gradually expanding for ancillary components, consumables, and information dissemination. Strategic segmentation analysis should therefore integrate product complexity, material constraints, end-user procurement behavior, and channel suitability to prioritize investments and operational focus.

Key regional dynamics and differentiated strategies that align regulatory landscapes, clinical practices, and procurement behaviors across major global markets

Regional dynamics are shaping competitive advantage through differing regulatory regimes, payer landscapes, and clinical infrastructures, and a geographically informed strategy is essential for effective market entry and expansion. In the Americas, strong private and public payer engagement combined with advanced surgical networks fosters rapid adoption of high-value implants, but it also demands rigorous evidence of cost effectiveness and longitudinal performance. Meanwhile, Europe, Middle East & Africa presents a heterogeneous environment in which regulatory harmonization efforts coexist with country-level reimbursement idiosyncrasies, requiring nimble market access planning and local partnerships to secure formulary placement and clinician endorsement.

In Asia-Pacific, a combination of high surgical volumes, growing healthcare investment, and favorable manufacturing ecosystems creates significant opportunities for scale, yet success depends on adapting products to local clinical practices and price sensitivity. Across these regions, differences in clinical training standards, procurement cycles, and hospital infrastructure necessitate region-specific clinical evidence packages, pricing strategies, and supply chain configurations. Therefore, thoughtful regional prioritization and tailored engagement models will accelerate adoption while reducing execution risk.

Insights into competitive behaviors where product platform thinking, clinical partnership, and supply chain resilience create measurable differentiation and commercial advantage

Leading companies in the bio-implant arena are demonstrating a mix of technology differentiation, clinical partnership, and operational discipline that defines competitive positioning. Successful organizations are investing in modular platform development to reduce time to market for variant devices and leveraging partnerships with leading clinical centers to generate robust real-world evidence. These firms also prioritize materials science innovation-combining advanced polymers, ceramics, and titanium alloys with surface treatments-to improve biocompatibility and reduce revision rates, thereby strengthening clinical and payer narratives.

Operationally, top performers are building resilient supply chains through multi-sourcing, regional manufacturing footprints, and digital traceability solutions to meet regulatory expectations and manage tariff exposure. In addition, companies that have integrated digital health capabilities around implantable devices-such as remote monitoring and data analytics-are creating differentiated propositions that support outcomes-based contracting and enhanced post-market surveillance. As a result, competitive advantage increasingly accrues to firms that combine clinical credibility, material and design innovation, and adaptable commercial models.

Actionable recommendations for leadership that combine product platform strategy, evidence generation, supply chain resilience, and targeted market access initiatives for measurable impact

Leaders should pursue a balanced agenda that accelerates innovation while de-risking commercialization through targeted investments and pragmatic operational changes. First, prioritize modular product platforms and design for manufacturability to enable component substitution and faster regulatory pathways. In parallel, invest in rigorous real-world evidence programs and structured post-market studies that demonstrate long-term outcomes and support payer negotiations. These data initiatives should be coordinated with clinical partners to ensure relevance and adoption.

Second, strengthen supply chain resilience by diversifying suppliers, evaluating near-shoring opportunities, and implementing digital traceability systems to improve inventory visibility and compliance. Third, tailor market access strategies to regional and end-user realities by aligning pricing, clinical evidence, and training programs with the specific needs of hospitals, ambulatory surgical centers, clinics, and research institutes. Finally, embrace digital adjuncts such as remote monitoring and patient engagement tools to enhance the value proposition of implants and facilitate outcome-driven contracting. Together, these actions will help organizations capture clinical trust, reduce operational risk, and unlock sustainable revenue pathways.

A clear description of the rigorous multi-method research approach, primary stakeholder interviews, and analytical techniques used to produce reliable and actionable insights

This report synthesizes a multi-method research approach combining primary qualitative interviews, secondary literature synthesis, and comparative case analysis to ensure analytical rigor and practical relevance. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and device engineers to capture diverse stakeholder perspectives on clinical utility, adoption barriers, and purchasing criteria. These insights were triangulated with secondary sources such as peer-reviewed clinical studies, regulatory filings, and publicly available policy documents to validate trends and corroborate technical claims.

Analytical methods employed comparative scenario analysis to test strategic responses under varying regulatory and trade conditions, and cross-regional benchmarking to identify best practices in market access and supply chain design. Quality control measures included source verification, expert peer review, and sensitivity checks to ensure findings are robust and actionable. Throughout, emphasis was placed on practical implications for product development, commercial strategy, and operational execution.

A concise concluding synthesis that reinforces strategic priorities for converting technological advances into clinical adoption and sustainable commercial success

In summary, the bio-implant sector sits at the intersection of rapid technological progress and heightened operational complexity, demanding integrated strategies that marry innovation with pragmatic execution. Stakeholders who align platform design, materials expertise, and robust real-world evidence with resilient supply chains and regionally tailored market access plans are best positioned to convert scientific advances into durable commercial success. Moreover, the evolving tariff and regulatory environment underscores the need for flexible manufacturing and sourcing strategies that protect margins without sacrificing clinical quality.

Looking ahead, organizations that proactively invest in clinician partnerships, post-market data systems, and digital adjuncts will not only enhance patient outcomes but also strengthen payer conversations and long-term viability. The path forward requires disciplined prioritization, cross-functional coordination, and a willingness to adapt business models to new evidence and geopolitical realities. By doing so, companies can capture emerging opportunities while managing the risks inherent in a rapidly changing global healthcare landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Advancements in biodegradable neural interface implants enhancing brain-computer communication
  • 5.2. Integration of wireless power transfer technology in cardiac bio-implant devices for long-term use
  • 5.3. Emergence of AI-driven predictive maintenance systems for optimizing performance of orthopedic implants
  • 5.4. Development of 3D-printed patient-specific bio-implant scaffolds with embedded growth factors to accelerate healing
  • 5.5. Regulatory convergence on global standards for safety testing of implantable bioelectronic medical devices

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-implant Market, by Product Type

  • 8.1. Cardiovascular Implants
    • 8.1.1. Artificial Heart Valves
    • 8.1.2. Pacemakers
    • 8.1.3. Stents
    • 8.1.4. Vascular Grafts
  • 8.2. Dental Implants
    • 8.2.1. Endosseous Implants
    • 8.2.2. Subperiosteal Implants
    • 8.2.3. Transosteal Implants
  • 8.3. Neurological Implants
    • 8.3.1. Deep Brain Stimulators
    • 8.3.2. Neuroprosthetics
    • 8.3.3. Spinal Cord Stimulators
  • 8.4. Ophthalmic Implants
    • 8.4.1. Corneal Implants
    • 8.4.2. Intraocular Lenses
    • 8.4.3. Retinal Implants
  • 8.5. Orthopedic Implants
    • 8.5.1. Hip Implants
      • 8.5.1.1. Hip Resurfacing
      • 8.5.1.2. Total Hip Replacement
    • 8.5.2. Knee Implants
      • 8.5.2.1. Partial Knee Replacement
      • 8.5.2.2. Total Knee Replacement
    • 8.5.3. Shoulder Implants
    • 8.5.4. Spinal Implants

9. Bio-implant Market, by Material

  • 9.1. Ceramic
  • 9.2. Composite
  • 9.3. Polymer
    • 9.3.1. Biodegradable Polymers
    • 9.3.2. Uhmwpe
  • 9.4. Titanium

10. Bio-implant Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Hospitals
  • 10.4. Research Institutes

11. Bio-implant Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Bio-implant Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bio-implant Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bio-implant Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. BioHorizons
    • 15.3.2. Dentsply Sirona Inc
    • 15.3.3. HIOSSEN
    • 15.3.4. Institut Straumann AG
    • 15.3.5. MEGA'GEN IMPLANT CO.,LTD.
    • 15.3.6. Nobel Biocare Services AG
    • 15.3.7. NuVasive, Inc.
    • 15.3.8. OSSTEM IMPLANT CO., LTD.
    • 15.3.9. Stryker Corporation
    • 15.3.10. Zimmer Biomet Holdings, Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIO-IMPLANT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIO-IMPLANT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIO-IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIO-IMPLANT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMPLANT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMPLANT MARKET SIZE, BY ARTIFICIAL HEART VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMPLANT MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMPLANT MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIO-IMPLANT MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIO-IMPLANT MARKET SIZE, BY ENDOSSEOUS IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIO-IMPLANT MARKET SIZE, BY SUBPERIOSTEAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIO-IMPLANT MARKET SIZE, BY TRANSOSTEAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIO-IMPLANT MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIO-IMPLANT MARKET SIZE, BY NEUROPROSTHETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIO-IMPLANT MARKET SIZE, BY CORNEAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIO-IMPLANT MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIO-IMPLANT MARKET SIZE, BY RETINAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIO-IMPLANT MARKET SIZE, BY HIP RESURFACING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL HIP REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIO-IMPLANT MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIO-IMPLANT MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIO-IMPLANT MARKET SIZE, BY SHOULDER IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIO-IMPLANT MARKET SIZE, BY SPINAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIO-IMPLANT MARKET SIZE, BY CERAMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIO-IMPLANT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIO-IMPLANT MARKET SIZE, BY POLYMER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIO-IMPLANT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIO-IMPLANT MARKET SIZE, BY UHMWPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIO-IMPLANT MARKET SIZE, BY TITANIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIO-IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIO-IMPLANT MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIO-IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIO-IMPLANT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIO-IMPLANT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIO-IMPLANT MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIO-IMPLANT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY NEUROLOGICAL IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY HIP IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY KNEE IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 330. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2018-2024 (USD MILLION)
  • TABLE 332. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY POLYMER, 2025-2032 (USD MILLION)
  • TABLE 333. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 334. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 335. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. LATIN AMERICA BIO-IMPLANT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPE, MIDDLE EAST & AFRICA BIO-IMPLANT MARKET SIZE, BY DENTAL IMPLANTS, 2018-2024 (US